Pseudomonas aeruginosa: all roads lead to resistance

Elena B. M. Breidenstein, César de la Fuente‐Núñez, Robert E. W. HancockTrends 2011 · DOI

TL;DR

Pseudomonas aeruginosa is a formidable pathogen known for its remarkable ability to develop antibiotic resistance through a complex interplay of intrinsic, acquired, and adaptive mechanisms. This review synthesizes recent research, highlighting the "resistome" – the vast collection of genes contributing to resistance – and emphasizing how these diverse pathways converge to make P. aeruginosa a significant clinical challenge.

What Problem Does This Paper Address?

Pseudomonas aeruginosa is a notorious "superbug," a Gram-negative bacterium that poses a significant threat in healthcare settings, particularly to immunocompromised individuals and those with chronic conditions like cystic fibrosis. Its ability to resist a wide array of antibiotics makes it incredibly difficult to treat, leading to prolonged infections and increased mortality. The core problem this paper addresses is understanding the multifaceted nature of P. aeruginosa's antibiotic resistance. While intrinsic resistance (due to its outer membrane permeability) and acquired resistance (through gene transfer) are well-known, the paper focuses on the increasingly recognized role of "adaptive resistance" – how the bacterium dynamically alters its gene expression and physiology in response to environmental cues, including sub-lethal antibiotic exposure, to become more resilient. This comprehensive understanding is crucial for developing new therapeutic strategies against this persistent pathogen.

Methods

The paper is a review, synthesizing findings from numerous primary research studies. The methods employed in the cited research are diverse and represent the cutting edge of microbial genetics and resistance research. These include:

  • Mutant Library Screens: Creating and screening large libraries of P. aeruginosa mutants to identify genes whose disruption leads to increased susceptibility to antibiotics. This is a systematic way to uncover novel resistance determinants.
  • Microarray Technologies: Analyzing the global gene expression patterns of bacteria under various conditions (e.g., antibiotic exposure, different growth states) to understand how resistance mechanisms are activated.
  • Mutation Frequency Analysis: Quantifying the rate at which mutations occur in specific genes or across the genome, particularly under stress conditions like antibiotic treatment or within biofilms, to identify hypermutable strains and their genetic basis.
  • Genomic Resistome Studies: Identifying the complete set of genes that, when mutated, contribute to resistance against a particular antibiotic or class of antibiotics.
  • In vivo and In vitro Studies: Evaluating antibiotic efficacy and resistance mechanisms in both laboratory settings and in relevant host environments (e.g., cystic fibrosis lungs, biofilms).

Datasets

Not discussed in the paper. The paper is a review and synthesizes data from numerous primary research articles, rather than presenting its own experimental datasets.

Key Insights and Ideas

  • The "Resistome" is Vast and Interconnected: P. aeruginosa possesses an extensive "resistome," meaning a large number of genes, when mutated, can confer resistance. These genes span diverse functional categories, suggesting that resistance is not a single pathway but a complex network.
  • Adaptive Resistance is a Dynamic and Crucial Strategy: Beyond static intrinsic or acquired resistance, P. aeruginosa can dynamically adapt its resistance mechanisms in response to environmental cues like sub-inhibitory antibiotic concentrations, nutrient availability, and growth state (biofilm, swarming). This adaptive resistance is often reversible but critically important for survival.
  • Biofilms and Swarming Motility are Hotbeds for Resistance: These complex social behaviors are not just about virulence; they are strongly linked to increased antibiotic resistance. Biofilms create a protected microenvironment, while swarming motility involves coordinated gene expression that can enhance resilience.
  • Virulence and Resistance are Often Co-regulated: Many regulatory genes and pathways influence both antibiotic resistance and virulence factors. This suggests that targeting virulence might indirectly impact resistance, and vice versa.
  • "Creeping Baselines" Lead to Breakthrough Resistance: Low-level resistance mutations can accumulate over time, gradually increasing the minimum inhibitory concentration (MIC) of antibiotics. This "creeping baseline" phenomenon can eventually lead to high-level, clinically untreatable resistance.

Key Results

  • P. aeruginosa exhibits high intrinsic resistance due to its low outer membrane permeability, which is 12-100 times less than E. coli.
  • Mutant library screens have identified dozens of genes contributing to resistance, revealing a complex "resistome."
  • Adaptive resistance can be triggered by various environmental factors, including antibiotics, biocides, polyamines, and changes in pH or nutrient availability.
  • Biofilm-associated communities show significantly higher resistance to antibiotics compared to planktonic cells.
  • Swarming colonies also exhibit greater resistance to multiple antibiotics.
  • Specific mutations can lead to significant increases in resistance, for example, a quadruple mutant showing a 16-fold increase in resistance to tobramycin.

Limitations and Future Work

  • In vitro vs. In vivo Efficacy: The paper highlights a significant discrepancy between antibiotic efficacy observed in vitro and in vivo. More in vivo studies are needed to accurately assess the real-world effectiveness of antibiotics.
  • Understanding Persister Cells: The mechanisms underlying the development of persister cells in P. aeruginosa are not fully understood, and these cells represent a significant challenge for eradication.
  • Developing New Strategies: The authors emphasize the urgent need for new drugs and therapeutic strategies to combat multidrug-resistant (MDR) P. aeruginosa. Future research should focus on unraveling the complexities of resistance to guide the development of more efficacious antimicrobials and strategies to minimize resistance issues.
  • Optimizing Antibiotic Dosages: The inappropriate use of antibiotics contributes to resistance, underscoring the need for better-defined optimal dosages in clinical settings.

Summary updated

BibTeX
@inproceedings{breidenstein2011pseudomonas,
  author = {Elena B. M. Breidenstein and César de la Fuente‐Núñez and Robert E. W. Hancock},
  title = {{Pseudomonas aeruginosa: all roads lead to resistance}},
  booktitle = {Trends},
  year = {2011},
  doi = {10.1016/j.tim.2011.04.005},
}
Figure